Emons Industries, Inc. v. Allen (In Re Emons Industries, Inc.)

220 B.R. 182, 1998 Bankr. LEXIS 542, 32 Bankr. Ct. Dec. (CRR) 591, 1998 WL 229761
CourtUnited States Bankruptcy Court, S.D. New York
DecidedApril 17, 1998
Docket15-12496
StatusPublished
Cited by4 cases

This text of 220 B.R. 182 (Emons Industries, Inc. v. Allen (In Re Emons Industries, Inc.)) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Emons Industries, Inc. v. Allen (In Re Emons Industries, Inc.), 220 B.R. 182, 1998 Bankr. LEXIS 542, 32 Bankr. Ct. Dec. (CRR) 591, 1998 WL 229761 (N.Y. 1998).

Opinion

MEMORANDUM DECISION GRANTING MOTION FOR SUMMARY JUDGMENT DECLARING THAT SUBSEQUENT DES CLAIMANTS ARE HOLDERS OF CLASS 5A CLAIMS ENTITLED TO A DISTRIBUTION UNDER THE DEBTOR’S CONFIRMED PLAN

PRUDENCE CARTER BEATTY, Bankruptcy Judge.

This Chapter 11 case was not a traditional one. It presented the need to deal with mass tort claims arising from a line of business long discontinued by the debtor in a situation in which virtually all of the debtor’s assets were subject to lien or were leased. The relevant mass tort law was in the process of evolving to create new theories of liability to deal with problems of proof confronting plaintiffs. At the same time, the bankruptcy courts were getting their first eases with mass tort liability issues. This case required a non-traditional response to the problems it presented. The particular approach chosen has worked well in this case but has not, apparently, been used in other cases. The Second Circuit has subsequently approved of other approaches to handling mass torts in bankruptcy cases that are not in conflict with the approach taken here. In this case some twelve years after confirmation, the plan distribution remaining available for ultimate payment to mass tort claimants is sufficient to cover all known and expected claims.

The debtor’s Chapter 11 plan of reorganization was confirmed in 1986. In 1989 the debtor commenced this adversary proceeding for a declaratory judgment that the plan and order of confirmation, including the dis *184 charge and injunction provisions, apply to the defendants. The defendants assert that they are not bound by the plan or order of confirmation because they did not receive actual notice of the last date for filing claims in the Chapter 11 case. The debtor urges that it is irrelevant that the defendants never received notice of the last date for filing claims (the “bar date”) because they are all holders of claims of the type expressly excluded from the scope of the bar date.

The claims for which no bar date was fixed were any claims based on exposure to die-thylstilbestrol (“DES”) 1 held by those who had not previously sued the debtor and whose identity was otherwise unknown to the debtor at the time the bar date was fixed (hereafter the “Subsequent DES Claimants”). The debtor seeks to have this court limit any distribution on the allowed claims of the Subsequent DES Claimants who are the defendants in this adversary proceeding to the distribution provided in the confirmed plan for other general unsecured claims, all of which were classified as Class 5A claims. The Subsequent DES Claimants want to be able to pursue their claims against the reorganized debtor from whom they believe they could obtain a greater recovery than the distribution provided for Class 5A claims under the confirmed plan, notwithstanding that it would give them a windfall in comparison with the treatment received by other DES Claimants in this Chapter 11 case.

The debtor has moved for summary judgment in its favor. Finding no material facts in dispute and for the reasons which follow, this court concludes that the debtor’s motion for summary judgment should be granted.

FINDINGS OF FACT 2

1.The debtor, Emons Industries, Inc. (“Emons” or “Debtor”), filed a petition for reorganization under Chapter 11 of the Bankruptcy Code on March 30, 1984 (the “Filing Date”) and continued as a debtor in possession. The Debtor was in the business of leasing and repairing railcars and through its subsidiaries operated two short line freight railroads. The filing of the Chapter 11 petition resulted from a lengthy and severe decline in the railcar leasing business in which the Debtor had been engaged for about 13 years. As of June 30, 1984, the Debtor and its subsidiaries had a shareholders’ deficit of $6,180,416 on its consolidated balance sheets. Disclosure Statement, Exhibit C at 36. The Debtor had concluded that it would have inadequate revenues to service its debt and lease obligations. Disclosure Statement at 4. Until the early 1970’s, the Debtor, as more fully described below, had also been in the pharmaceutical drug business.

2. The common stock of the Debtor was publicly held. According to the Chapter 11 petition there were about 3,000 holders of the 4,974,233 outstanding shares of the Debtor’s voting common stock. The Debtor also had three series of preferred stock — two series of which had only two holders and one series of which had 1,000 holders. Disclosure Statement at 4.

3. On the Filing Date, a small number of financial institutions held security interests in substantially all of the Debtor’s assets or were the lessors of the railcars and other equipment utilized by the Debtor. The dollar amount of the secured debt exceeded the value of the Debtor’s assets. At the time the Chapter 11 petition was filed, each non-tort creditor of the Debtor with more than a de minimis claim was also a secured creditor or a lessor (collectively the “Institutions”). Almost all of the Institutions held substantial unsecured deficiency or potential lease rejection claims because of the deterioration in the market value of railcars. An Official Committee of Creditors was appointed on *185 April 17, 1984. 3 The Creditors’ Committee was composed entirely of the Institutions. Disclosure Statement at 4-5.

4. The Debtor was the successor to Grant Chemical Co. (“Grant”) and Amfre-Grant, Inc. (“Amfre-Grant”). Grant and Amfre-Grant were among more than 100 companies which sold DES. DES was prescribed to at least 600,000 women. The DES distributed by Grant and Amfre-Grant was unusual in that it was uniquely identifiable by color and shape. However, the Debtor was neither a significant factor with respect to the nationwide sale of DES, nor was it a significant factor in the drug industry. Disclosure Statement at 6.

5. In 1971, an article was published in which the author urged that there was an association between maternal ingestation of DES and clear cell adenocarcinoma of the vagina of young women. The Federal Drug Administration withdrew its approval of DES in Fall 1971. Thereafter, and prior to the time the Debtor filed its chapter 11 case in 1984, numerous lawsuits were brought throughout the United States against DES manufacturers and distributors asserting damages arising out of maternal ingestion. Few plaintiffs were in a position to identify which company’s DES had caused their injuries. This led to the development of new theories of liability under which the manufacturers and distributors could be held liable. 4 Among the theories of liability is the market-share theory on the basis of which all manufacturers and distributors are liable to DES plaintiffs in proportion to their share of the market. The Debtor has been determined to have a minor market share.

6. In August 1986, the Debtor sought to have this court fix the last day for filing claims.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United Refining Company
S.D. Texas, 2021
In re Johns-Manville Corp.
552 B.R. 221 (S.D. New York, 2016)
In Re Quigley Co., Inc.
383 B.R. 19 (S.D. New York, 2008)
In Re Union Hosp. Ass'n of Bronx
226 B.R. 134 (S.D. New York, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
220 B.R. 182, 1998 Bankr. LEXIS 542, 32 Bankr. Ct. Dec. (CRR) 591, 1998 WL 229761, Counsel Stack Legal Research, https://law.counselstack.com/opinion/emons-industries-inc-v-allen-in-re-emons-industries-inc-nysb-1998.